MHealth Market Will Be Worth $49.12 Billion By 2020: Grand View Research, Inc.

 

The global mHealth market size is expected to reach USD 49.12 billion by 2020, growing at a CAGR of 47.6% from 2013 to 2020, according to a new report by Grand View Research, Inc. Monitoring services is expected to grow at an estimated CAGR of 49.7% from 2014 to 2020.

Growing aging population along with rising incidences of chronic diseases such as cancer, heart ailments, and diabetes is anticipated to drive market demand. Introduction of new generation connected medical devices; healthcare providers find it easy to offer medical services at reduced costs.

Browse full research report on mhealth market: www.grandviewresearch.com/industry-analysis/mhealth-market                                 

Growing need to maintain a secure infrastructure for data safety and security is anticipated to restrain mobile health market growth. On account of the increasing healthcare expenditures, affordability and availability of healthcare services is expected to pose a challenge to the mHealth industry.

The mHealth market can be segregated on the basis of services and participants. Services include healthcare systems strengthening, diagnosis services, monitoring services, and other services. Participants include content players, healthcare providers, device vendors and mobile operators.

mhealth-market
U.S. mHealth market by service (USD Million), 2012 – 2020

Monitoring services include chronic disease management, independent aging solutions, and post acute care services. Diagnosis services particularly, enable healthcare professionals to connect with patients for offering diagnosis of ailments as well as health related issues. Regulatory support is expected to drive the use of aforementioned services demand which further includes interoperability and standardization.

Mobile operators accounted for 48% of the overall market in 2012, with majority of their revenue originating from monitoring services such as independent aging solutions. Mobile operators offer varied solutions along with connectivity services which include health call centers, content-based wellness information, and mobile telemedicine. Device vendors are engaged in offering tools for transmitting captured information over mobile networks.

Driven by the need for accessible healthcare, the Asia Pacific market is expected to the fastest growing regional market, at an estimated CAGR of 49.1% from 2014 to 2020. Low penetration of medical practitioners and growing rural population in Asia Pacific region are expected to open avenues for revenue generation. Furthermore, North America is expected to hold a considerable share in global market over the forecast period on account of increasing health projects and high smartphones penetration.

Leading players emphasize on investment on research & development and strengthening competitiveness with the introduction of innovative solutions. Key players include AT&T, Vodafone, Apple, Allscripts Healthcare Solutions, Qualcomm Inc., and Samsung Electronics Corporation and mQure.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare                                                                                                                                                                   Grand View Research has segmented the global mHealth market on the basis of services, participants and region:

mHealth Services Outlook (Revenue, USD Million, 2012 – 2020)

  • Monitoring Services
    • Independent Aging Solutions
    • Chronic Disease Management
    • Post Acute Care Services
  • Diagnosis Services
  • Healthcare Systems Strengthening Services
  • Others

mHealth Participants Outlook (Revenue, USD Million, 2012 – 2020)      

  • Mobile Operators
  • Device Vendors
  • Content Players
  • Healthcare Providers

mHealth Regional Outlook (Revenue, USD Million, 2012 – 2020)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • Italy
    • Russia
    • UK
  • Asia Pacific
    • Australia
    • India
    • China
    • Japan
  • RoW

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-mHealth-market                                                                     

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Advertisements

Boosting Demand Of Wireless Health Market Due To Rising Healthcare Expenditure Prompting Cost-Cutting Initiatives Till 2025

 

The global wireless health market size is expected to reach USD 315.4 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 23.5% CAGR during the forecast period. Increase in number of eHealth initiatives worldwide, increase in penetration of smartphones and Internet connectivity, and growth in the trend of self-disease management are some of the factors boosting market growth. Growing trend toward use of wearable devices for monitoring physical parameters, such as sleep, blood pressure, heart rate, and physical activity, is also driving the wireless health market.

Growing geriatric population and subsequent rise in chronic disease burden is also driving the market. According to The Wall Street Journal, there has been an increase in usage of digital medicine, which enables management of chronic conditions such as diabetes, heart diseases, and respiratory diseases. Moreover, these digital medicines are cost-effective alternatives to traditional disease management.

north-america-wireless-health-market.png

Shifting trend toward value-based care is another factor contributing to the growth of the wireless health market. At present, some of the telehealth services, such as consulting a doctor via video connection, are reimbursed by CMS. Use of digital services such as various platforms for health management has promoted the development of various applications for managing diabetes, heart diseases, and asthma. Use of applications for chronic disease management, fitness tracking, supporting medication adherence, preventing hospital readmissions, symptom tracking, and managing mental and behavioral health are on the rise.

Browse full research report on Wireless Health Market: www.grandviewresearch.com/industry-analysis/wireless-health-market                       

Further key findings from the study suggest:                     

  • Wireless Personal Area Network (WPAN) emerged as the largest technology segment and Wireless Wide Area Network (WWAN) is anticipated to witness the fastest growth over the coming years
  • Software emerged as the largest component segment owing to rise in number of research initiatives. The services segment, on the other hand, is anticipated to expand at the fastest CAGR of 24.7%
  • Patient-specific applications emerged as the largest segment owing to increase in adoption and rise in research initiatives for developing them to manage individual health
  • The patient segment accounted for the largest revenue share in terms of end use owing to increase in use of health and fitness applications by people around the world
  • Themarket is highly fragmented with participants such as IBM; Allscripts; Cerner Corporation; Omron Corporation; Koninklijke Philips N.V.; Epic Systems Corporation; and Evolent Health, Inc.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare                                                                                                                                                                   Grand View Research has segmented the global wireless health market report on the basis of technology, component type, application, end use, and region:

Wireless Health Technology Outlook (Revenue, USD Billion, 2014 – 2025)

  • WLAN/Wi-Fi
  • WPAN
  • WiMAX
  • WWAN

Wireless Health Component Type Outlook (Revenue, USD Billion, 2014 – 2025)

  • Software
  • Hardware
  • Services

Wireless Health Application Outlook (Revenue, USD Billion, 2014 – 2025)

  • Patient-specific
    • Physiological monitoring
    • Patient communication and support
  • Provider specific

Wireless Health End-use Outlook (Revenue, USD Billion, 2014 – 2025)

  • Providers
  • Payers
  • Patients/Individuals

Wireless Health Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • SouthAfrica

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-wireless-health-market                                                                                                                                               

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Hormonal Contraceptive Market Will Be Worth $26.2 Billion By 2025: Grand View Research, Inc.

 

The global hormonal contraceptive market size is expected to reach USD 26.2 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 4.0% during the forecast period. Introduction of innovative products in the market and growing awareness about reproductive and sexual health in emerging regions are likely to drive the market in the coming years.

Pill, Intrauterine Devices (IUD), injectable, vaginal rings, implants, and patches are various methods used for hormonal contraception. Hormonal contraception methods act on the endocrine system to prevent ovulation.

us-hormonal-contraceptive-market-report.png

Increasing number of women in developing economies are using contraceptives due to rise in government initiatives and programs, which is anticipated to accelerate market growth. For instance, according to the UN, approximately 64.0% of women between 15 and 49 years of age were using some form of family planning in 2015, be it traditional or modern. This figure stood at 36.0% in 1970.

The number of unintended pregnancies annually is highest in U.S., which is about 3 million. Hence, the Center for Medicaid and CHIP Services (CMCS) established a Maternal and Infant Health Initiative for the Medicaid and Children’s Health Insurance Program (CHIP) program to promote use of effective methods of contraception and help women avoid such pregnancies.

Browse full research report on Hormonal Contraceptive Market: www.grandviewresearch.com/industry-analysis/hormonal-contraceptive-market               

Further key findings from the study suggest:                     

  • Increasing demand for contraceptive methods can be attributed to growing awareness about pills and devices, increasing significance of family planning, and supportive government regulations improving access to these products
  • In 2016, pills accounted for the largest share in the market as they are convenient to use and exhibit more than 99.0% effectivity when accurately consumed. Furthermore, ease of availability, fewer adverse effects, and large number of players operating in the market can be attributed to this share
  • The IUD segment is expected to witness the fastest growth during the forecast period. This can be attributed to entry of new devices in the market over the recent past, availability of long-acting reversible birth control methods, and more than 99.0% effectivity
  • Geographically, North America held the largest share in 2016 and is anticipated to maintain its dominance during the forecast period due to local presence of market players, high per capita income, and supportive government initiatives
  • Asia Pacific is estimated to witness the fastest growth during the forecast period due to high unmet need, expected increase in coverage during the next 15 years, and increasing number of women of reproductive age
  • Some of the key players operating in the market are Teva Pharmaceuticals Industries Ltd.; Bayer AG, Merck & Co. Inc.; Pfizer, Afaxys, Inc.; Agile Therapeutics; Allergan; and Apothecus Pharmaceutical Corporation.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare                                                                                                                                                                   Grand View Research has segmented the global hormonal contraceptive market on the basis of method and region:

Hormonal Contraceptive Method Outlook (Revenue, USD Million, 2014 – 2025)

  • Pill
  • Intrauterine Devices (IUD)
  • Injectable
  • Vaginal Ring
  • Implant
  • Patch

Hormonal Contraceptive Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-hormonal-contraceptive-market                                          

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Medical Animation Market Is To Be $514 Million By 2024: Grand View Research, Inc.

 

The global medical animation market is expected to reach a value of USD 514.0 million by 2024, according to a new report by Grand View Research. Key factors driving the market growth include the higher adoption of medical animation marketing by medical devices manufacturers and pharmaceutical products. It helps in explaining product features and communicating associated information with end users.

The information represented by animation is more appealing and easy to transmit. These aforementioned benefits are expected to boost the usage rate in near future. In addition, the paradigm shift, in healthcare information technology, such as digitalization, is anticipated to contribute towards the market growth in the next few years. The medical animation market has gained momentum after the introduction of cloud-based platforms and 3D printing technology in healthcare.

us-medical-animation-market
U.S. medical animation market, by type, 2014 – 2025 (USD Million)

Furthermore, the introduction of technologically advanced software for image analysis, such as Medical Image Processing, Analysis, and Visualization can be attributed to the market growth. This application enables researcher from remote sites share valuable information and analyze the research data to detect, monitor, and treat medical disorders.  Medical animation is a versatile tool for communicating complex scientific procedures in an interactive manner and used in a variety of business aspects such as marketing, web presentations, social media, tradeshows and advertising. Increasing adoption of this technology is expected to serve as a potential growth driver in the future.

The increasing investment by private and public sector, growing geriatric population coupled with increasing demand for computer-aided diagnostics, and incidence of chronic diseases are major factors fueling the increasing usage rates of this technology. In addition, this technology found application in various sectors, for instance; it helps healthcare professionals explain human body metabolism to patients, which helps in reducing patient’s anxiety level and educates them about various disease condition.

Browse full research report on Medical Animation Market: www.grandviewresearch.com/industry-analysis/medical-animation-market            

Further key findings from the study suggest:

  • Flash animation is expected to be one of the most lucrative segment in near future due to increasing demand for patient engagement by healthcare professionals. On the other hand, 3D animation found application in clinical research studies, improving patient education, and simplifying complex procedures in bioscience studies by representing them into an animated form
  • Growing demand for technologically advanced medical animation solutions is expected to contribute towards the growth of 3D animation during the forecast period
  • In 2015, the drug mechanism of action segment accounted for the largest revenue share. The use of animation for explaining drug interactions and metabolic studies in new drug development are key contributing factors for this segment growth. This technology is used in animating preproduction, full production and post production process of drug molecules
  • However, the patient education segment is expected to emerge as the fastest growing segment as awareness levels amongst patients, introduction of user-friendly apps and concerns related to health information are increasing. For instance, introduction of 3D medical application such as complete anatomy in November 2015 by 3D4 medical used for anatomical studies
  • Currently, oncology segment dominates the market and is expected to be the fastest growing therapeutic area using this technology. Increasing incidence of cancer worldwide is a key contributing factor for growing demand of medical animation studies to explain disease mechanisms to patients
  • For instance, XVIVO, showcased animation software at the American Society of Clinical Oncology (ASCO) and also helped in the depiction of mechanism of action of Bavituximab, an investigative drug, believed to strengthen the immunity system in cancerous environment
  • Other end users of this market are life science companies, medical device manufactures, government authorities, forensic department, medico-legal firms, and insurance provider companies. This segment is expected to grow at fastest CAGR due to wide usage of 3D bioprinting and biosimulation studies in these fields
  • For example, in forensic studies, a medical animation is used to elaborate crime scene and medico-legal firms use 3D animation to explain pain management procedures, surgical techniques, and presenting anatomical studies. There are various surgical and clinical audiovisual animation studies available online
  • Asia Pacific is expected to be the fastest growing region during the forecast period. The growing geriatric population, increase in the chronic diseases, and ongoing development in healthcare sector is the factors anticipated to provide future growth platform for this industry in the next 7 years
  • In addition, rising outsourcing activities in this region due to availability and low cost of labor are anticipated to propel segment growth over the forecast period. For example, in India, the cost of medical animation services is 20% to 25% lower than the U.S. and Europe
  • The medical animation market is experiencing high competition as there are many small and big organization that offer these services. Introduction of low-cost software solutions for medical simulation is expected to boost the competition and is also expected to benefit several end users over the forecast period
  • Companies are involved in adopting sustainable strategies to gain competitive edges such as new product launch, product up gradation and collaborative agreements. For example, In April 2016, Fusion medical animation launched biotech brand services aimed at designing and developing innovative visuals for better understanding of complex products The aforementioned factors keeps the market rivalry at higher level

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare                                                                                                                                                    Grand View Research has segmented the medical animation market by type, application, therapeutic area, end-use and region:

Medical Animation Market Type Outlook (Market revenue in USD Million, 2013 – 2024)

  • 3D Animation
  • 2D Animation
  • 4D Animation
  • Flash Animation

Medical Animation Market Application Outlook (Market Revenue in USD Million, 2013 – 2024)

  • Drug MoA
  • Patient Education
  • Surgical Training & Planning
  • Cellular & Molecular Studies
  • Others

Medical Animation Stationary Therapeutic Area Outlook (Market Revenue in USD Million, 2013 – 2024)

  • Oncology
  • Cardiology
  • Plastic Surgery
  • Dental
  • Others

Medical animation Market End-use Outlook (Market Revenue in USD Million, 2013 – 2024)

  • Hospitals
  • Life sciences
  • Academic institute
  • Medical device manufactures
  • Others

Medical Animation Market Regional Outlook (Market Revenue in USD Million, 2013 – 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-medical-animation-market                                                      

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Boosting Demand Of Breast Lesion Localization Methods Market Due To Rising Prevalence Of Breast Cancer Among Women Till 2025

 

The global breast lesion localization methods market is expected to reach USD 1.57 billion by 2025, according to a new report by Grand View Research, Inc. The increasing government and non-government reimbursement policies for mammary gland cancer diagnosis, biopsy, pre-surgical examinations, and other treatment options is estimated to increase the adoption of breast lesion localization procedures. For instance, the Alabama Breast and Cervical Cancer Early Detection Program aims to provide breast and cervical oncology diagnostic and screening services to women who meet certain income, age, and insurance coverage eligibility guidelines.

us-breast-lesion-localization-methods-market.png
U.S. breast lesion localization methods, by type, 2014 – 2025 (USD Billion)

Furthermore, rising prevalence of breast cancer is anticipated to propel the market growth. The disease is highly prevalent amongst women belonging to the age group of 65 years or above. The maximum risk of mammary gland cancer is between the age of 70 and 79. On the other hand, men are also at a risk of breast cancer. In the U.S., median age of men at diagnosis is approximately 68 years.

Browse full research report on Breast Lesion Localization Methods Market: www.grandviewresearch.com/industry-analysis/breast-lesion-localization-methods-market                                                                                                                              

Further key findings from the report suggest:

  • Wire localization biopsy dominated the market in 2016 owing to its higher usage by healthcare practitioners, easy availability, and presence of a wide product range
  • Magnetic tracer is expected to grow at lucrative CAGR of 14.0% over the forecast period as a result of increasing adoption of MagSNOLL technology over conventional wire localization.
  • Radioisotope seed localization is considered the most preferred method amongst all radioisotope localization methods due to its benefits such as ease of localization few weeks before the excision surgery and lesser need for reoperation.
  • North America is estimated to be the largest regional market. It dominated the market in terms of revenue with USD 185.04 million in 2016 owing to the presence of well-established healthcare services and increasing number of oncology surgeries being performed.
  • In addition, early adoption of devices and shift from traditional to technologically advanced products by healthcare providers are some of the factors anticipated to increase the demand for localization devices in this region
  • Asia Pacific is expected to be the fastest growing region over the next decade with lucrative CAGR from 2017 to 2025 due to growing awareness about breast screening among the people. Furthermore, presence of a large target population and rising disposable income are some of the factors expected to propel the growth of this region.
  • Key players in this industry are Cianna Medical, Inc.; Cook Medical; STERYLAB; CP Medical; SOMATEX Medical Technologies; Argon Medical Devices, Inc.; and C.R BARD, Inc.
  • Most of the key players are focusing on strategies such as expansion of their product portfolios and collaborations, mergers, & acquisitions. In November 2015, C.R. BARD, Inc. announced the acquisition of Liberator Medical Holdings, Inc., a direct-to-customer distributor of medical products.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare                                           

Grand View Research has segmented the global breast lesion localization methods market on the basis of type and region:

Breast Lesion Localization Methods Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Wire Localization biopsy
  • Radioisotope localization
    • Radio-guided occult lesion localization
    • Radioactive seed localization
    • Others
  • Magnetic tracer
  • Others

Breast Lesion Localization Methods Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-breast-lesion-localization-methods-market                              

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Pharmerging Market Boosting Due To Increasing Healthcare Expenditure Till 2025: Grand View Research, Inc.

 

The global pharmerging market is expected to reach USD 2,231.9 billion by 2025, according to a new report by Grand View Research, Inc. This market is expected to grow due to increasing geriatric population, increasing disease burden of chronic disorders and increasing healthcare expenditure.

According to the United Nations (UN), the number of people above the age of 60 years are estimated to be 901 million in 2015. This number is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050. The increasing geriatric population boosts the demand for better treatment options for chronic diseases such as hyperlipidemia, hypertension, cancer, dementia, congestive heart failure. According to a study conducted by Deloitte in 2011, the geriatric population accounts for almost 23.0-40.0% of the prescription drug market, and 40.0-50.0% of the OTC drug market.

tier-i-healthcare-market.png

Another driving factor for the pharmerging market is increasing healthcare expenditure. The global healthcare spending is expected to increase from USD 7.83 trillion in 2013 to USD 18.28 trillion in 2040. It has also been estimated that there will an increase of 3.4%, 3.0%, 2.4% in healthcare expenditure in upper middle-level income countries, lower middle-level income countries and in low-income level countries respectively.

The increasing disease burden of chronic diseases in developing countries is boosting the growth in the market. According to the Global Health Observatory data, in 2015, 70.0% of the deaths were due to non-communicable diseases (NCD). The major NCDs are cardiovascular diseases (CVD) which caused 45.0% of all NCD deaths, cancer which caused 22.0% of all NCD deaths and chronic obstructive pulmonary disease (COPD) which causes 10.0% of all NCD deaths, and diabetes which caused 4.0% of all NCD deaths.

Browse full research report on Pharmerging Market: www.grandviewresearch.com/industry-analysis/pharmerging-market        

Further key findings from the report suggest:

  • Pharmaceutical segment was the major contributor for the pharmerging market in 2016.
  • Pharmaceutical sector also recorded the fastest growth in the pharmerging industry.
  • Tier I is driving growth in the pharmerging market.
  • India among the Tier II countries is estimated to witness the fastest growth in the pharmerging industry.
  • Brazil was recorded as the major contributor for Tier II countries.
  • Among Tier III countries, Nigeria and Indonesia are estimated to be driving growth.
  • The key players include Sanofi, Pfizer Inc., AstraZeneca, GlaxoSmithKline, F.Hoffmann-La Roche, GE Healthcare, Eli Lilly, Medtronic, Johnson and Johnson, Abbott.
  • The key strategic initiatives include new product launches, acquisitions and mergers, and collaborations.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare                                   

Grand View Research has segmented the pharmerging market by product, and region:

Pharmerging Regional Outlook (Revenue, USD Billion; 2014 – 2025)

  • Tier I
    • China
  • Tier II
    • India
    • Brazil
    • Russia
    • South Africa
  • Tier III
    • Argentina
    • Mexico
    • Poland
    • Ukraine
    • Turkey
    • Saudi Arabia
    • Egypt
    • Algeria
    • Nigeria
    • Thailand
    • Indonesia
    • Pakistan
    • Saudi Arabia

Pharmerging Product Outlook (Revenue, USD Billion; 2014 – 2025)

  • Pharmaceutical
    • Patented prescription drugs
    • Generic prescription drug
    • OTC drugs
  • Other healthcare verticals
    • Medical device
    • Clinical diagnostics
    • Other

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-pharmerging-market                                     

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

 

Women’s Health Market To Experience Lucrative Growth Due To Child Or Early Marriages Till 2025: Grand View Research, Inc.

 

The global women’s health market is expected to reach USD 51.3 billion by 2025, according to a new report by Grand View Research, Inc. Increasing female geriatric population, introduction of various drugs related to women’s health, and favorable government policies are some of the factors expected to drive growth during the forecast period.

us-womens-health-market.png

Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years. According to International Osteoporosis Foundation, global prevalence of osteoporosis among women was over 200.0 million in 1990, and this is anticipated to reach 680.0 million in 2050.

Government and various private organizations are working toward improving women’s health across the world, and this is likely to drive growth in the coming years. Reimbursement coverage provided to women is also a key factor driving the market in developed countries. For instance, various coverage plans in the U.S. provide preventive services for women without charging any copayment. These include screening for anemia, hepatitis B, & breast cancer on a routine basis, folic acid supplements for women who are likely to be pregnant, and contraceptive methods, among others.

Browse full research report on Women’s Health Market: www.grandviewresearch.com/industry-analysis/womens-health-market

Further key findings from the report suggest:

  • Presence of a large female geriatric population, which is susceptible to chronic diseases, is expected to boost growth
  • In 2016, postmenopausal osteoporosis accounted for the largest share of the market due to high incidence of osteoporosis in women after menopause, presence of several major players, and cost-effectiveness of this treatment
  • Contraceptive segment is likely to witness fastest growth during the forecast period due to increase in awareness and usage, government initiatives, technological developments, and favorable regulatory scenario. For instance, in June 2017, Agile Therapeutics, Inc. resubmitted an NDA for Twirla, an investigational low-dose combined hormonal contraceptive patch
  • Geographically, North America held the largest share of more than 30% in 2016 due to presence of major market players, high awareness about regular health check-ups for women, coverage for screening, and increased healthcare expenditure
  • Asia Pacific is expected to exhibit fastest growth during the forecast period due to increasing investments by players in the region, rising awareness about women’s health, and initiatives by various governments and private organizations to improve awareness and access to women’s health products
  • Some of the key players operating in the women’s health market are Allergan; Bayer AG; Merck & Co., Inc.; Pfizer, Inc.; Teva Pharmaceutical Industries Ltd.; Agile Therapeutics; Amgen, Inc.; AstraZeneca; Bristol-Myers Squibb Company; and Ferring B.V.

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/healthcare                                                               

Grand View Research has segmented the global women’s health market on the basis of application and region:

Application of Women’s Health Outlook (Revenue, USD Million, 2014 – 2025)

  • Postmenopausal Osteoporosis
  • Infertility
  • Endometriosis
  • Contraceptives
  • Menopause
  • Polycystic Ovary Syndrome (PCOS)

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-womens-health-market                  

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com